Drug intelligence / Profile preview

Translational Therapeutics eIF4E small molecule

Development stage
Unknown
Lead developer
Translational Therapeutics
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

A **preclinical to early clinical-stage small-molecule antineoplastic program** from **Translational Therapeutics** designed to inhibit or modulate the oncogenic translation factor **eukaryotic translation initiation factor 4E** and disrupt its reported \"gating\" role in malignant mRNA translation. The program is being positioned for **eIF4E-driven cancers**, described by the company as **4E cancers**, and has been presented as **IND-ready** and preparing for initiation of a **Phase 1/2** study in an orphan oncology setting. No distinct non-proprietary name, code name, brand name, formulation, or route of administration was identified from the provided materials.

Other names
Translational Therapeutics eIF4E small moleculeeIF4E small moleculeeIF-4E small moleculeeIF 4E small molecule4E cancers small molecule
02

Targets

EIF4E (Eukaryotic translation initiation factor 4E)

Beyond the preview

Go deeper on Translational Therapeutics eIF4E small molecule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Translational Therapeutics eIF4E small molecule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call